miR-195 inhibits PC progression by targeting the RPS6KB1 gene (encoding the ribosomal protein S6 serine/threonine kinase B1), which is involved in mTOR signaling, promoting protein synthesis, cell growth, and cell proliferation. Here, MTOR is linked to pachyonychia congenita.